Hanna Karvonen
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 17, 2022
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention.Juuli Raivola, Alice Dini, Hanna Karvonen
|Aug 07, 2021
Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR Inhibitors.Dafne Jacome Sanz, Juuli Raivola, Hanna Karvonen
|Sep 29, 2020
Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness.Hanna Karvonen, Mariliina Arjama, Laura Kaleva
|Aug 07, 2019
Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.Hanna Karvonen, Harlan Barker, Laura Kaleva
|Jan 12, 2019
Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.Hanna Karvonen, Robert Perttilä, Wilhelmiina Niininen
|Jul 11, 2018
Targeting Wnt signaling pseudokinases in hematological cancers.Hanna Karvonen, Robert Perttilä, Wilhelmiina Niininen
Pageof 1
